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ABSTRACT 
 
Background: Sustaining treatment adherence and long-term virological suppression is 
a global health challenge in HIV management. Mobile phone-based interventions are 
increasingly harnessed to enhance medication adherence in HIV infection, although 
supporting evidence for implementation is limited by lack of robust efficacy trials in 
settings such as India. The overall aim of this thesis was to assess whether customized 
mobile phone reminders would improve adherence to therapy and thus decrease 
virological failure among HIV-infected patients initiating anti-retroviral treatment 
(ART) within the Indian national AIDS control program, and to investigate factors 
related to the success of this intervention within this population. 
Methods: To test the feasibility and acceptability of the mobile phone-based reminder 
system, we conducted a 12-month single center pilot study among 150 HIV-infected 
ART-experienced patients (Study I). Subsequently we conducted a two-year 
randomized controlled trial at three sites in southern India (Bangalore, Mysore and 
Chennai), where 631 eligible ART-naïve patients were enrolled (Studies II, III, IV). 
The intervention consisted of weekly interactive voice reminders, along with a weekly 
pictorial text message for two years. Patients were monitored for pill count adherence 
measurements, adherence barriers, drug toxicity, CD4 counts and viral load every three 
months.  
Results: The results of the pilot study indicated good acceptability and feasibility of the 
intervention, however a definite beneficial effect on adherence was inconclusive. 
(Study I). Analysis of the randomized controlled trial revealed no observed statistically 
significant difference in time to virological failure or sub-optimal adherence (mean 
adherence <95%) between the intervention and control groups, even after adjusting for 
potential confounders (Study II). Virological failure was associated with lower 
adherence levels, non-tenofovir drug regimens and primary drug resistance. Adherence 
levels and barriers varied significantly over time. The commonly reported barrier, 
‘forgetfulness’ was not associated with virological failure. Significant determinants of 
optimal adherence were older age, higher level of education, greater disclosure status, 
and patients’ satisfaction with health status, medications and healthcare access (Study 
III). ART toxicity related to zidovudine and nevirapine was associated with lower levels 
of adherence, particularly in the first 6 months after ART initiation (Study IV). 
Conclusions: The results of this thesis indicate that mobile phone-based reminders 
alone may not improve adherence and promote treatment success among HIV-infected 
patients. Adherence behavior is a complex dynamic process with a multitude of diverse 
influencing factors. Optimal adherence and treatment success may be better sustained 
by minimizing drug interruptions for medical reasons, use of safer first-line ART 
regimens, and strengthening both patient self-efficacy and patient-health provider 
relationships.  
 
